Healthscope Ltd (HSO):企業の財務・戦略的SWOT分析

◆英語タイトル:Healthscope Ltd (HSO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C9030
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Healthscope Ltd (HSO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Healthscope Ltd (Healthscope) is an integrated healthcare provider that provides healthcare services through the ownership and management of hospitals and medical centers including skin clinics and a specialist breast diagnostic clinic. Its hospitals provide a range of acute, medical, maternity, mental health and rehabilitation services. The hospital also provides pathology diagnostic services in New Zealand, Malaysia, Singapore and Vietnam ; and accommodation, in-home services and attendant care to individuals with acquired brain injuries, disabilities. Healthscope also provides veterinary pathology throughout New Zealand through Gribbles Veterinary. The company operates in Australia, New Zealand and South East Asia. Healthscope is headquartered in Melbourne, Victoria, Australia.

Healthscope Ltd Key Recent Developments

Feb 15,2018: Healthscope 2018 First Half Results
Jan 08,2018: Healthscope Appoints Michael Stanford To Board
Aug 23,2017: Healthscope 2017 Full Year Results
Apr 03,2017: Gordon Ballantyne to succeed Robert Cooke as Healthscope Managing Director and CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Healthscope Ltd – Key Facts 5
Healthscope Ltd – Key Employees 6
Healthscope Ltd – Key Employee Biographies 7
Healthscope Ltd – Major Products and Services 8
Healthscope Ltd – History 9
Healthscope Ltd – Company Statement 11
Healthscope Ltd – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 15
Company Overview 15
Healthscope Ltd – Business Description 16
Healthscope Ltd – SWOT Analysis 17
SWOT Analysis – Overview 17
Healthscope Ltd – Strengths 17
Healthscope Ltd – Weaknesses 18
Healthscope Ltd – Opportunities 19
Healthscope Ltd – Threats 20
Healthscope Ltd – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Healthscope Ltd, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Feb 15, 2018: Healthscope 2018 First Half Results 32
Jan 08, 2018: Healthscope Appoints Michael Stanford To Board 35
Aug 23, 2017: Healthscope 2017 Full Year Results 36
Apr 03, 2017: Gordon Ballantyne to succeed Robert Cooke as Healthscope Managing Director and CEO 39
Section 6 – Appendix 40
Methodology 40
Ratio Definitions 40
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Healthscope Ltd, Key Facts 5
Healthscope Ltd, Key Employees 6
Healthscope Ltd, Key Employee Biographies 7
Healthscope Ltd, Major Products and Services 8
Healthscope Ltd, History 9
Healthscope Ltd, Other Locations 13
Healthscope Ltd, Subsidiaries 13
Healthscope Ltd, Key Competitors 21
Healthscope Ltd, Ratios based on current share price 22
Healthscope Ltd, Annual Ratios 23
Healthscope Ltd, Annual Ratios (Cont...1) 24
Healthscope Ltd, Annual Ratios (Cont...2) 25
Healthscope Ltd, Interim Ratios 27
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Healthscope Ltd, Recent Deals Summary 31
Currency Codes 40
Capital Market Ratios 40
Equity Ratios 41
Profitability Ratios 41
Cost Ratios 42
Liquidity Ratios 42
Leverage Ratios 43
Efficiency Ratios 43

List of Figures
Healthscope Ltd, Performance Chart (2014 - 2018) 26
Healthscope Ltd, Ratio Charts 28
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

★海外企業調査レポート[Healthscope Ltd (HSO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Siemens Healthcare GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Siemens Healthcare GmbH d/b/a Siemens Healthineers, a subsidiary of Siemens AG, is a global medical device company that designs, develops, manufactures and distributes medical devices and technologies for diagnostic markets. Its major products include healthcare IT, laboratory diagnostics eq …
  • Apex Oil Company, Inc.:企業の戦略・SWOT・財務分析
    Apex Oil Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apex Oil Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Epiroc AB (EPI A):企業の財務・戦略的SWOT分析
    Epiroc AB (EPI A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PolyNovo Ltd (PNV)-医療機器分野:企業M&A・提携分析
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd is a medical device company that develops, manufactures and commercializes biodegradable polymers for use in medical devices. The company offers products such as biodegradable temporizing matrix and negative pressure wound therapy dressing system …
  • ERG Renew SpA:電力:M&Aディール及び事業提携情報
    Summary ERG Renew S.p.A. (ERG Renew), formerly Entad S.p.A., a subsidiary of ERG S.p.A, is a power company that generates electricity from renewable sources. The company generates electricity mainly through wind. ERG Renew and its subsidiaries operate in Italy, France, Bulgaria/Romania, Germany, and …
  • Globin Solutions Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Globin Solutions Inc (Globin) is a pre-clinical stage biotechnology company with focus on the research and development of antidotal medicines for human poisoning. Its lead compound, Ngb H64Q, an antidote, a mutant version of the protein neuroglobin, has been found to scavenge carbon monoxide …
  • Redcape Hotel Group:企業の戦略・SWOT・財務分析
    Redcape Hotel Group - Strategy, SWOT and Corporate Finance Report Summary Redcape Hotel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Martifer SGPS SA (MAR):企業の財務・戦略的SWOT分析
    Martifer SGPS SA (MAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • MicroPort Scientific Corp (853):医療機器:M&Aディール及び事業提携情報
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company which develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, e …
  • Amryt Pharma Plc (AMYT):企業の財務・戦略的SWOT分析
    Amryt Pharma Plc (AMYT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Panhandle Oil and Gas Inc. (PHX):石油・ガス:M&Aディール及び事業提携情報
    Summary Panhandle Oil and Gas Inc (Panhandle) sells oil, natural gas liquid (NGL) and natural gas produced from non-operated assets through working interests, royalty interests and both in producing oil and natural gas wells and those in the process of being drilled or completed. The company operate …
  • Vascular Biogenics Ltd (VBLT):企業の財務・戦略的SWOT分析
    Summary Vascular Biogenics Ltd (VBL) is a clinical biopharmaceutical company that discovers, develops and commercializes treatments for cancer. The company’s product pipeline includes VB-111. VBL’s product VB-111 is an anti-angiogenic agent for the specific inhibition of tumor vascular growth for ca …
  • Perpetual Energy Inc (PMT):石油・ガス:M&Aディール及び事業提携情報
    Summary Perpetual Energy Inc (Perpetual Energy) is an upstream oil and gas company. It explores, develops and produces from shallow gas, liquids-rich gas, heavy oil, bitumen and other assets. The company produces light and medium crude oil, heavy oil natural gas and natural gas liquids. Perpetual En …
  • Solaria Energia y Medio Ambiente SA (SLR):企業の財務・戦略的SWOT分析
    Solaria Energia y Medio Ambiente SA (SLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Imaging Dynamics Company Ltd (IDL)-医療機器分野:企業M&A・提携分析
    Summary Imaging Dynamics Company Ltd (IDC) is a medical technology company that offers solutions in medical imaging and digital radiography technology. The company provides flat panel technology, CCD technology, 2200 X-series, 1600 Plus X-series, 1600 X-series, 1590 X-series, image processing softwa …
  • Valentino Fashion Group S.p.A:企業の戦略・SWOT・財務情報
    Valentino Fashion Group S.p.A - Strategy, SWOT and Corporate Finance Report Summary Valentino Fashion Group S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Evotec AG (EVT):医療機器:M&Aディール及び事業提携情報
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • BASF India Ltd (BASF):企業の財務・戦略的SWOT分析
    Summary BASF India Ltd (BASF) a subsidiary of BASF SE is a chemical company that manufactures and distributes specialty chemicals, performance products, plastics and crop protection products. The company offers chemical products such as intermediates, monomers and petrochemicals. Its performance pro …
  • Rexnord Corp (RXN):企業の財務・戦略的SWOT分析
    Rexnord Corp (RXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Ambry Genetics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Ambry Genetics Corp (Ambry Genetics), a subsidiary of Konica Minolta Inc, is a provider of clinical genetic testing services. The company provides genetic diagnosis for various conditions including hereditary cancer, epilepsy, hereditary cardiovascular disease and neurodevelopmental disorder …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆